Evaluating lipid-driven insulin resistance via TyG index in breast cancer patients: Toward effective secondary prevention
GMS German Medical Science · 2025-10-01 · 23 (Doc11) · Doc11
DOI: 10.3205/000347 ↗At a glance
Journal article in GMS German Medical Science, published on 2025-10-01. Written by Bandana Kumari and 1 co-authors. Institution: Department of Biochemistry, All India Institute of Medical Sciences, Patna, Bihar, India. Major MEDLINE topics: Insulin Resistance, Breast Neoplasms, Triglycerides, Blood Glucose. Cited 2 times so far (Crossref). The full text is freely available (open access, CC BY 4.0).
Topics: Onkologische Pflege
Abstract (original language)
Objective
Breast cancer is the most commonly diagnosed malignancy worldwide. Insulin resistance (IR) plays a key role in its progression by activating oncogenic signaling pathways. The triglyceride-glucose (TyG) index is a validated, cost-effective surrogate marker for IR. This study aims to evaluate the prevalence of IR in female breast cancer patients using the TyG index and to identify lipid parameters associated with increased IR, thereby supporting strategies for secondary prevention.
Methods
A cross-sectional study was conducted among non-diabetic, histopathologically confirmed female breast cancer patients. Demographic data, lipid profiles, and fasting glucose levels were collected. Participants were stratified into high-risk (TyG≥8.87) and low-risk (TyG
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Biochemistry, All India Institute of Medical Sciences, Patna, Bihar, India.
- All India Institute of Medical Sciences, Patna, Bihar, India.
Cite
APA
Kumari, B., & Lahariya, R. (2025). Evaluating lipid-driven insulin resistance via TyG index in breast cancer patients: Toward effective secondary prevention. GMS German Medical Science, 23(Doc11), Doc11. https://doi.org/10.3205/000347
Vancouver
Kumari B, Lahariya R. Evaluating lipid-driven insulin resistance via TyG index in breast cancer patients: Toward effective secondary prevention. GMS German Medical Science. 2025;23(Doc11):Doc11. doi:10.3205/000347
BibTeX
@article{Kumari2025,
author = {Kumari, Bandana and Lahariya, Rijhul},
title = {Evaluating lipid-driven insulin resistance via TyG index in breast cancer patients: Toward effective secondary prevention},
journal = {GMS German Medical Science},
year = {2025},
volume = {23},
number = {Doc11},
pages = {Doc11},
doi = {10.3205/000347}
}
EUVIMED